Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients.

Jae-Hoon KoEun-Jeong JooSu-Jin ParkJin Yang BaekWon Duk KimJaehwan JeeChul Joong KimChul JeongYae-Jean KimHye Jin ShonEun Suk KangYoung Ki ChoiKyong-Ran Peck

Published in: Journal of clinical medicine (2020)

Most asymptomatic and mild COVID-19 patients produced the neutralizing antibody, although the titers were lower than pneumonia patients. ELISA and FIA sensitively detected anti-SARS-CoV-2 antibodies.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
ejection fraction
newly diagnosed
intensive care unit
patient reported outcomes
coronavirus disease
acute respiratory distress syndrome
zika virus
extracorporeal membrane oxygenation